CEBP CTRC-AACR San Antonio Breast Cancer Symposium 2008 Conference on Cancer Prevention - Washington, D.C.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Evans, A. A.
Right arrow Articles by London, W. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Evans, A. A.
Right arrow Articles by London, W. T.

Cancer Epidemiology Biomarkers & Prevention, Vol 7, Issue 7 559-565, Copyright © 1998 by American Association for Cancer Research


ARTICLES

Geographic variation in viral load among hepatitis B carriers with differing risks of hepatocellular carcinoma

AA Evans, AP O'Connell, JC Pugh, WS Mason, FM Shen, GC Chen, WY Lin, A Dia, S M'Boup, B Drame and WT London
Division of Population Science, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA. A_Evans@fccc.edu

The risk of hepatocellular carcinoma (HCC) varies significantly among hepatitis B virus (HBV) carriers from different geographic regions. We compared serological markers of HBV infection in adult male carriers from Haimen City, China and Senegal, West Africa, where the prevalence of chronic infection is similar. HCC mortality among HBV carriers is much higher in Haimen City than it is in Senegal (age-standardized rate, 878 versus 68 per l0(5) person-years). A dramatic difference was observed when HBV DNA levels in serum were assessed among carriers by Southern blot. In the Senegalese group (n = 289), 14.5% were HBV DNA positive by Southern blot in their 20s, and this percentage declined in each subsequent decade of age to 3.3, 2.9, and 0% thereafter. In the Chinese group (n = 285), a higher prevalence of HBV DNA positivity and a less consistent reduction were seen; 29.4% were positive in their 20s, and 30.2, 23.6, and 20.6%, respectively, were positive in each subsequent decade of age. Among 102 male Asian-American HBV carriers, the prevalence of HBV DNA positivity was intermediate between the Chinese and Senegalese populations (36.8, 10.7, 3.0, and 4.6% in each subsequent decade of age). Viral titers were similar among those who were HBV DNA positive in all three populations [median value, 10(7) virions/ml (range, 10(6)-10(9) virions/ml)]. The presence of HBV DNA in serum was positively associated with serum glutathione S-transferase, a marker of liver damage. These findings suggest that the more prolonged maintenance of productive virus infection in the Chinese carriers compared with the Senegalese carriers may explain their higher risk of HCC. This profound difference in the natural history of chronic infection may be due to earlier age of infection in China or to as yet unknown environmental or genetic factors.


This article has been cited by other articles:


Home page
CarcinogenesisHome page
G. D. Kirk, E. Bah, and R. Montesano
Molecular epidemiology of human liver cancer: insights into etiology, pathogenesis and prevention from The Gambia, West Africa
Carcinogenesis, October 1, 2006; 27(10): 2070 - 2082.
[Abstract] [Full Text] [PDF]


Home page
CA Cancer J ClinHome page
D. Schottenfeld and J. Beebe-Dimmer
Chronic inflammation: a common and important factor in the pathogenesis of neoplasia.
CA Cancer J Clin, March 1, 2006; 56(2): 69 - 83.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M.-W. Yu, S.-H. Yeh, P.-J. Chen, Y.-F. Liaw, C.-L. Lin, C.-J. Liu, W.-L. Shih, J.-H. Kao, D.-S. Chen, and C.-J. Chen
Hepatitis B Virus Genotype and DNA Level and Hepatocellular Carcinoma: A Prospective Study in Men
J Natl Cancer Inst, February 16, 2005; 97(4): 265 - 272.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
E. Q. Konnick, M. Erali, E. R. Ashwood, and D. R. Hillyard
Evaluation of the COBAS Amplicor HBV Monitor Assay and Comparison with the Ultrasensitive HBV Hybrid Capture 2 Assay for Quantification of Hepatitis B Virus DNA
J. Clin. Microbiol., February 1, 2005; 43(2): 596 - 603.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
L. F. Steel, M. G. Trotter, P. B. Nakajima, T. S. Mattu, G. Gonye, and T. Block
Efficient and Specific Removal of Albumin from Human Serum Samples
Mol. Cell. Proteomics, April 1, 2003; 2(4): 262 - 270.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
F.-M. Suk, M.-H. Lin, M. Newman, S. Pan, S.-H. Chen, J.-D. Liu, and C. Shih
Replication Advantage and Host Factor-Independent Phenotypes Attributable to a Common Naturally Occurring Capsid Mutation (I97L) in Human Hepatitis B Virus
J. Virol., October 25, 2002; 76(23): 12069 - 12077.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
F. Cainelli and S. Vento
Sequelae and Serologic Outcome in Persons with Hepatitis B Virus Infection
Ann Intern Med, October 1, 2002; 137(7): 619 - 619.
[Full Text] [PDF]


Home page
Microbiol. Mol. Biol. Rev.Home page
C. Seeger and W. S. Mason
Hepatitis B Virus Biology
Microbiol. Mol. Biol. Rev., March 1, 2000; 64(1): 51 - 68.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1998 by the American Association for Cancer Research.